Loading clinical trials...
Loading clinical trials...
Indication to Transplant Patients With High Risk B Cells Lymphoma in Metabolic Complete Remission After 2 Cycles of Chemotherapy ?
Conditions
Interventions
Autograft
Locations
1
France
Institut Paoli-Calmettes
Marseille, France
Start Date
July 3, 2017
Primary Completion Date
July 28, 2019
Completion Date
July 28, 2019
Last Updated
September 24, 2018
NCT04161248
NCT06528301
NCT05940272
NCT06534437
NCT05463263
NCT06609304
Lead Sponsor
Institut Paoli-Calmettes
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions